Thermo Fisher Scientific TMO Equity Method Income
Equity Method Income at other companies
Other financials
Where this comes from
Reported directly by Thermo Fisher Scientific in its filing.
Tagged under the XBRL concept us-gaap:IncomeLossFromEquityMethodInvestments.
The official record: Thermo Fisher Scientific’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →
Ask your AI about Thermo Fisher Scientific's equity method income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Thermo Fisher Scientific's equity method income?
- Thermo Fisher Scientific (TMO) reported equity method income of -$8M in Q1 2026.
- How has Thermo Fisher Scientific's equity method income changed year-over-year?
- Thermo Fisher Scientific's equity method income increased by 42.9% year-over-year, from -$14M to -$8M.
- What is the long-term trend for Thermo Fisher Scientific's equity method income?
- Over 2 years (2021 to 2023), Thermo Fisher Scientific's equity method income has grown at a 284.1% compound annual growth rate (CAGR), from -$4M to -$59M.
- What does equity method income mean?
- The company's proportional share of net income or loss from unconsolidated affiliates and joint ventures accounted for under the equity method.